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Abstract
Ubiquitination - the linkage of one or more molecules of the protein ubiquitin to another protein -
regulates a wide range of biological processes in all eukaryotes. We review the proteome-wide
strategies that are being used to study aspects of ubiquitin biology, including substrates,
components of the proteasome and ubiquitin ligases, and deubiquitination.
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Ubiquitin, a small protein of 76 amino acids, is highly con-
served in all eukaryotes. In a multi-step process, ubiquitin is
covalently linked to lysine residues of substrate proteins. If a
single molecule of ubiquitin is linked to a protein, this is
referred to as mono-ubiquitination, a process that is of partic-
ular importance for protein trafficking but has also been
shown to regulate retrovirus budding and to modulate
protein function directly [1]. A lysine residue of a ubiquitin
molecule attached to a substrate can itself serve as an accep-
tor for an additional ubiquitin molecule, and this process can
be repeated so that poly-ubiquitinated proteins form. Poly-
ubiquitin chains serve as recognition signals for the 26S pro-
teasome, the major regulator of protein abundance in cells,
and poly-ubiquitination thus often initiates proteolysis of the
substrate. But poly-ubiquitination can also regulate protein
function directly without affecting stability, in ways similar to
mono-ubiquitination and other post-translational modifica-
tions. The mechanisms underlying proteolysis-independent
regulation by poly-ubiquitination are only poorly understood
but might function by changing conformation or adding or
obscuring a binding site (Figure 1; for reviews see [1-3]).
The transfer of ubiquitin is a multi-step process that involves
at least three classes of enzymes: ubiquitin-activating
enzymes, generally called E1 enzymes; ubiquitin-conjugating
enzymes or E2s; and ubiquitin ligases, E3s (Figure 1). E3
ubiquitin ligases are of particular importance because they
confer substrate specificity to the system by interacting
directly with substrate proteins and thereby directing the
transfer of ubiquitin. The human genome encodes an esti-
mated 500-600 ubiquitin ligases, a number comparable to
the 518 predicted kinases [4,5]. If you consider that each
ubiquitin ligase is active on several substrates, you can get
some impression of the complexity and importance of the
ubiquitin system.
Ubiquitination is a highly dynamic process and is balanced
by deconjugation of ubiquitin by deubiquitinating enzymes
(DUBs). The more than 70 DUBs that are estimated to be
encoded in the human genome are responsible for the
reversible nature of ubiquitin modifications and have impor-
tant roles in recycling ubiquitin from proteasome substrates,
in stabilizing proteins by counteracting their poly-ubiquiti-
nation, and in opposing the proteolysis-independent regula-
tory roles of ubiquitin modifications (for reviews see [6,7]).
DUBs together with E1, E2 and E3 enzymes and the protea-
some make up the ubiquitin-proteasome system.
The large number of proteins that constitute the ubiquitin-
proteasome system and the enormous number of ubiquitina-
tion substrates mean that global approaches are required if
we are to understand fully the role of ubiquitination in cell
biology, development, and disease. Large-scale studies of the
entire system are still in their early stages, but they havealready made important contributions to the field. Here, we
review the approaches taken in some of these studies and
their findings.
Proteomic approaches to characterizing the
ubiquitin-proteasome system
Multi-protein complexes and protein-protein interactions
have important roles in the ubiquitin-proteasome system.
Both the 26S proteasome (see Figure 1c) and E3 ubiquitin
ligases have been studied extensively using protein-complex
purification coupled with mass-spectrometric protein identi-
fication [8-11]. Studies of the subunit composition of protea-
somes from various organisms have revealed that the 26S
proteasome complex consists of the 20S complex (made up
of seven  and seven  subunits) and the 19S complex (made
up of six ATPase and twelve non-ATPase subunits) [12]. The
20S complex is well characterized as forming the catalytic
core; the 19S regulatory complex is believed to be responsi-
ble for substrate recognition and unfolding (Figure 1c), but
the specific functions of most of the 19S subunit components
are still not well understood. There is accumulating evidence
for a non-proteolytic role for the proteasome in processes
such as transcription, chromatin packaging, and DNA repair
[13,14]. Additional subunits found in the majority of protea-
some complexes have been identified following the develop-
ment of new protein-purification and protein-identification
techniques [8,15]. Recently, hybrid 26S proteasome com-
plexes have been characterized, in which one copy of the 19S
is present at one end of the 20S core and the other end is
capped by Bml10, a newly characterized HEAT repeat
protein in yeast. Blm10 and its mammalian ortholog PA28
function as 20S activators [16,17]. These complexes seem to
have labile structures that cannot be preserved during the
purification steps. Although the hybrid complexes reconsti-
tuted in vitro have higher peptidase activity than the classic
versions, their roles in the degradation of ubiquitinated sub-
strates in vivo are unclear [16,17]. Given the heterogeneous
population and functional diversity of the various protea-
some complexes, it remains a challenging task to purify and
identify the subpopulations of proteasome complexes and to
correlate the differences in their composition with their
distinct functions in vivo.
A diverse groups of proteasome-interacting proteins, includ-
ing ubiquitin ligases, DUBs, heat-shock proteins and many
other proteins have been identified by affinity purification and
mass spectrometry as well as from genome-wide two-hybrid
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Figure 1
The ubiquitin proteasome system. (a) Ubiquitin is activated by a ubiquitin-activating enzyme (E1) and transferred onto substrate proteins by ubiquitin-
conjugating enzymes (E2) and ubiquitin ligases (E3), resulting in (b) either attachment of a single ubiquitin molecule (mono-ubiquitination), attachment of
multiple ubiquitin units to several substrate lysine residues on the same protein (multi-ubiquitination) or synthesis of ubiquitin chains (poly-ubiquitination). (c)
Many poly-ubiquitinated proteins are subsequently degraded by the 26S proteasome, which consists of the catalytic 20S complex and the regulatory 19S
particles. Degradation substrates are either delivered to the proteasome by soluble ubiquitin receptors or recognized by the intrinsic ubiquitin-binding
activity of the 19S particle. At the 19S proteasome the ubiquitin chain is disassembled, and the substrate is unfolded before it can enter the cavity of the
20S subunit where proteolysis takes place. Finally, proteolytic fragments exit the proteasome in a poorly understood way. (d) Ubiquitination can also
directly regulate protein function in a proteolysis-independent manner, via mono-, multi- or poly-ubiquitinated proteins.
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Ub Ub Ubscreens for protein-protein interactions [8,15,18-21]. Many
of the identified interactions seem to be labile under condi-
tions of active ATP hydrolysis by the 19S regulatory complex
because addition of ATP coincides with the release of the
interacting proteins [8]. This modulation has been suggested
to be a part of the mechanism of protein degradation [22].
New methodologies are needed if we are to identify and
characterize proteasome-interacting proteins fully, to under-
stand how the different interacting proteins influence the
catalytic cycle, and to clarify how they link the ubiquitin-
proteasome system to other biological processes.
Mass-spectrometric approaches have also contributed much
to our current understanding of the complex composition of
E3 ubiquitin ligases. Two types of ubiquitin ligase that play
important roles in cell-cycle regulation have been exten-
sively investigated: SCFs and the anaphase-promoting
complex/cyclosome (APC/C). SCF ubiquitin ligases are
named after three of their four subunits - Skp1, Cdc53 (also
known as Cul1) and one member of the F-box protein family -
and they also include the Ring-H2 protein Hrt1 (also known
as Roc1 or Rbx1) [23]. The substrate specificity of SCFs
depends on the different F-box proteins that are tethered to
the Cdc53-Hrt1 ubiquitin-ligase module by Skp1. Using
sequential rounds of epitope tagging, affinity purification
and mass spectrometry (a procedure called SEAM), Skp1
was found to form a variety of complexes, including some
that are most likely to have functions other than
ubiquitination [9,24,25].
In comparison, proteomic approaches have shown that the
APC/C, which regulates mitosis, has a more complex struc-
ture than SCFs with at least 13 components [26]. Despite
some success in identifying the subunits and also the modifi-
cations of APC/C, the molecular functions of the individual
subunits are largely unknown. Exceptions are the RING-
finger subunit Apc11 and the cullin-like subunit Apc2, which
are believed to have a direct role in ubiquitin transfer [27]. 
Perhaps because of the large number of ubiquitin ligases
present in the genome, ubiquitin-ligase proteomics is still in
its infancy. Affinity purification coupled with mass spectrom-
etry has promised great advances in the study of the composi-
tion of protein complexes and the identification of their
interacting partners. But further advancements in proteomic
research are expected to provide more information on the
protein complexes involved in the ubiquitin-proteasome
system, including their post-translational modifications, the
stoichiometry of their subunits and how they are assembled. 
Identification of ubiquitination substrates in vitro
The large number of putative E3 ubiquitin ligases makes sys-
tematic characterization of their substrates a formidable task,
but it is one that will be important if we are to gain a global
view of the dynamics of the ubiquitin system. E3-substrate
interactions are generally only transient, and substrates are
usually either degraded by the proteasome and/or released
from the E3 ligase after the transfer of ubiquitin. This makes
detection of E3-ligase-substrate interactions difficult. Two-
hybrid assays have successfully identified some substrates of
ubiquitin ligases [28], but identification of proteins that can
interact with E3 ligases does not necessarily pinpoint sub-
strates. A more effective strategy is to identify E3 substrates by
their ubiquitination or degradation by the 26S proteasome. 
One of the first effective large-scale attempts used Xenopus
oocyte extracts to identify substrates of the APC/C, a ubiqui-
tin ligase that regulates mitosis [29-32]. The approach
exploited the unique regulation of APC/C activity: it is inac-
tive during interphase but active during mitosis. When
added to mitotic extracts, APC/C substrates are ubiquiti-
nated and rapidly degraded by the proteasome, but the same
substrates are unchanged in interphase lysates. In a large-
scale approach Xenopus cDNA clones that had been in vitro-
translated  and labeled were divided into small pools and
incubated with interphase and mitotic oocyte extracts. Pro-
teins that disappeared specifically from mitotic extracts were
isolated, and this led to the identification of several important
APC/C substrates, including cyclin B, the DNA-replication
inhibitor geminin, and the anaphase inhibitor securin [29-32].
A different in vitro approach was applied to identifying the
potential substrates of the ubiquitin ligase that is formed by
a heterodimer of BRCA1 and BARD1 [33,34]; the
BRCA1/BARD1 heterodimer functions as a tumor suppres-
sor that is important for protection from breast and ovarian
cancer, and its ubiquitin-ligase activity has been linked to its
protective function [35]. Sato and colleagues [33] immuno-
precipitated BRCA1/BARD1 complexes, which were added to
a ubiquitination reaction in vitro, that used ubiquitin tagged
with the FLAG epitope. The rationale behind the approach
was that substrates of ubiquitination by BRCA1 should be
bound to the immunoprecipitated BRCA1 and subsequently
ubiquitinated with FLAG-ubiquitin in vitro. Proteins conju-
gated to FLAG-ubiquitin were purified and identified by
mass spectrometry [33]. A more directed strategy restricted
the hunt for BRCA1-BARD1 substrates to components of the
centrosome [34], because BRCA1 has been implicated in the
regulation of centrosome duplication [36]. Starita and col-
leagues [34] incubated mammalian centrosome-containing
cell fractions with recombinant BRCA1-BARD1 ligase com-
plexes and biotinylated ubiquitin. Ubiquitinated proteins
were detected through the biotin tag on ubiquitin and subse-
quently identified by mass spectrometry [34]. Both of these
strategies [33,34] identified promising candidate BRCA1-
BARD1 substrates - nucleoplasmin/B23 [33] and -tubulin
[34] - that might be connected to the tumor-suppressor
function of BRCA1. A high-throughput strategy has also been
used to identify substrates of the yeast ubiquitin ligase Rsp5
in vitro. A luminescent assay involving biotinylated ubiqui-
tin was used to screen several hundred purified yeast
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ously known, as well as new, candidate substrates of Rsp5
were identified [37]. 
A more general in vitro approach [38] used total HeLa cell
lysates for large-scale identification of ubiquitinated pro-
teins. Cell lysates were incubated with ubiquitin tagged with
six histidines (6xHis-ubiquitin) and an ATP-regenerating
system to sustain ubiquitination in vitro. The 6xHis-ubiqui-
tin was covalently attached to proteins by the E1, E2, and E3
enzymes present in the cell lysates, and this allowed purifica-
tion of ubiquitinated proteins on the basis of the affinity of
6xHis-ubiquitin to Ni2+ ions (Ni-chelate chromatography)
[38]. Over 100 ubiquitin-linked proteins were identified by
mass spectrometry, of which a relatively high proportion was
already implicated in the ubiquitin proteasome pathway,
such as E2 and E3 enzymes and proteasome subunits.
Because relatively mild purification conditions were chosen,
both ubiquitinated proteins and proteins associated with
them were identified. This is illustrated by the identification
of 16 out of 18 subunits of the 19S proteasome; covalent
modification of 19S proteasome subunits with ubiquitin has
so far not been reported, but an intrinsic affinity of the 19S
proteasome for poly-ubiquitin chains is well known [39] and
is most likely to be responsible for the identification of these
proteins in the study [38]. Bona fide ubiquitinated proteins
can be distinguished from associated, copurifying proteins
by fractionation strategies that use highly denaturing condi-
tions and break non-covalent interactions. Such stringent
purification conditions have been widely used to demon-
strate covalent attachment of ubiquitin to specific proteins
[40], as well as in proteome-wide approaches to identifying
ubiquitinated proteins, as discussed below.
Ubiquitination substrates in vivo
Identification of all ubiquitinated proteins in a cell under a
given growth condition or developmental state is an ambi-
tious aim, but it no longer seems impossible given the
tremendous pace at which mass-spectrometry-based pro-
teomics is developing (reviewed in [41]). Ubiquitin profiling
was pioneered by Peng and colleagues [42] and usually
involves expression of 6xHis-tagged ubiquitin in cells
(Figure 2). The cellular ubiquitin system conjugates 6xHis-
ubiquitin to target proteins and allows their purification by
Ni-chelate chromatography. Because Ni-chelate purifica-
tion is compatible with fully denaturing conditions, proteins
that are associated with ubiquitinated proteins but are not
ubiquitination substrates themselves can efficiently be
removed. The purified ubiquitinated proteins are frag-
mented by trypsin (or similar proteases) to generate pep-
tides, which can be used for mass-spectrometric
identification of the proteins present in the purified frac-
tion. More than 1,000 candidate ubiquitination substrates
were identified using this method in the relatively simple
eukaryote  Saccharomyces cerevisiae [42], whose genome
encodes roughly 5,800 proteins. Surprisingly, most of the
well-studied (and less abundant) ubiquitinated proteins
were absent from the list, suggesting that many more yeast
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Figure 2
Global strategies that use mass spectrometry (MS) to study ubiquitination.
(a) Diagram of the lysine residues in ubiquitin; the carboxy-terminal Arg-
Gly-Gly (RGG) motif is also indicated. (b) In ubiquitin profiling, 6xHis-
tagged ubiquitin expressed in cells is conjugated to substrate proteins, and
this facilitates purification of ubiquitinated proteins under denaturing
conditions by Ni-chelate chromatography, in which histidine-tagged
proteins bind specifically to immobilized Ni2+ ions. Purified ubiquitinated
proteins are digested with trypsin and the resulting peptides are analyzed
by mass spectrometry to identify the proteins present in the sample.
(c) Precise ubiquitination sites can be determined by mass spectrometry
because of a characteristic mass shift caused by diglycine that is retained
on ubiquitinated lysine residues within peptides after trypsin digestion.
(d) A similar strategy allows differentiation between the various types of
ubiquitin chain linkage that can lead to diverse ubiquitin-chain topologies.
Depending on the lysine residue in ubiquitin that was used for the
ubiquitin-ubiquitin linkage, different linkage-specific signature peptides with
characteristic masses are produced by trypsin digestion. These signature
peptides can be detected and distinguished by mass spectrometry.
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Ubproteins than the identified 1,000 candidates are ubiquiti-
nation substrates. 
At first glance, it seems that a surprisingly large fraction of
the proteome is ubiquitinated. But misfolded proteins,
which can be generated by translation inaccuracy, folding
problems or oxidative damage, are ubiquitinated and
degraded as part of the protein quality-control pathway [43].
One can therefore expect that at least a small fraction of any
protein will be ubiquitinated, and that sufficiently sensitive
analytical methods might find that all proteins can be ubiq-
uitination substrates. It is important to bear in mind that
current ubiquitin-profiling experiments can indicate only
whether any of a given protein is ubiquitinated but cannot
give any estimate of what fraction of the protein is ubiquiti-
nated. This imposes some limitations on how the results of
large-scale studies can be interpreted.
To find more specific substrates of the ubiquitin-proteasome
system, recent proteomic approaches have focused on specific
parts of the system. Ubiquitin profiling has been used success-
fully to study the endoplasmic reticulum associated degrada-
tion pathway (ERAD) [44]. Membrane-enriched fractions
from yeast cells expressing 6xHis-ubiquitin were used as a
starting material for purification of ubiquitinated proteins and
their subsequent identification by mass spectrometry. More
than 80 candidate ERAD substrates were identified [44].
Mayor and colleagues [45] enriched for proteasome substrates
on a poly-ubiquitin-binding protein resin and followed this
with denaturing Ni-chelate chromatography in order to
purify ubiquitinated proteins from yeast cells expressing
6xHis-ubiquitin. Remarkably, by profiling a yeast strain with
a mutation in the proteasomal ubiquitin receptor Rpn10, they
could identify 54 candidate ubiquitination substrates that
require Rpn10 for degradation [45]. Among them were the
transcription factor Gcn4 and the cell cycle regulator Sic1,
two known proteasome substrates whose abundance is low.
This study [45] demonstrates how subtractive ubiquitin pro-
filing can help to define substrates of particular pathways of
the ubiquitin-proteasome system. It is not hard to imagine
that a similar strategy, in which cells defective in a particular
E3 ligase are compared with wild-type cells, could be used
for large-scale identification of the specific substrates of
individual ubiquitin ligases. Furthermore, the introduction
to proteomic analyses of various mass-spectrometric
strategies that use stable isotope labeling promises to
transform ubiquitin-profiling experiments by enabling
detection of quantitative changes in ubiquitin profiles [46-48].
Ubiquitination sites and ubiquitin-chain topology
The pioneering ubiquitin-profiling experiments of Peng and
colleagues [42] demonstrated the feasibility of large-scale
identification of ubiquitin-attachment sites in substrate
proteins. This is possible because, after trypsin digestion, the
two carboxy-terminal residues of ubiquitin remain attached
to the lysine residue of the substrate protein (Figure 2c).
These two additional glycine residues lead to a characteristic
114 Da increase in the mass of the ubiquitinated substrate
peptide, which is diagnostic for the ubiquitinated residue
and can be monitored by mass spectrometry [42]. Over 100
precise ubiquitin attachment sites have been identified by
analyzing peptide-mass data from global ubiquitin-profiling
experiments [42,44]. Bioinformatic analyses of these data
sets showed that ubiquitination sites are almost exclusively
exposed on the protein surface, and located preferentially in
a sequence environment that is predicted to form a loop
structure [49]. No conserved ubiquitination motif could be
defined, however.
A related strategy allowed detection of different ubiquitin
chain topologies in vivo [42,50]. Formation of a poly-ubiqui-
tin chain requires isopeptide linkages between the terminal
carboxyl group of a free ubiquitin molecule and one of seven
lysine residues present in a substrate-attached ubiquitin
(Figure 2a,d). The most important chain topology is formed
through the lysine in position 48 of ubiquitin [51]. Chains
linked through Lys48 are the principal recognition signals
for the proteasome and generally induce substrate degrada-
tion [52]. Chains linked through Lys63 do not induce sub-
strate degradation but have direct effects on protein activity
[53,54]; the biological role of other ubiquitin chain topolo-
gies is unclear. From the analytical perspective, the ubiquitin
chain linkage can be regarded as a specific example of a
ubiquitination site in a substrate: the substrate in this case is
ubiquitin itself. Chain linkage can therefore be determined
by the characteristic 114 Da mass shift, as described above
(Figure 2c,d) [41]. 
Rather surprisingly, analysis of mass data from large-scale
ubiquitin-profiling experiments [42] has revealed that all
seven lysine residues in ubiquitin are used to form ubiquitin
chains in vivo. The abundance of the different chain-linkage
types was ranked and suggested that linkage through Lys48
is the most abundant topology, followed by Lys63 and Lys11
chains and the less frequent linkages through Lys33, Lys27,
Lys6, and Lys29 (the latter is detected only in combination
with Lys33 linkage) [42]. These results emphasize the com-
plexity of ubiquitin biology. At the same time, interpretation
of these experiments [42] is somewhat limited because they
can describe only the linkage between two ubiquitins and
cannot determine to which protein the chain was attached
or whether the chain was attached to a substrate at all
(Figure 2d). Similarly, it is unclear whether ubiquitin chains
are homogenous or can contain mixed linkage types. The
only rigorously studied example so far of a substrate-
attached ubiquitin chain in vivo demonstrated the presence
of a homogenous ubiquitin chain [50]. Many more studies
are necessary, however, before we can decide whether mixed
chains exist in vivo and whether they encode biologically
important information.
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Genome Biology 2005, 6:233Chemistry-based and global in vivo approaches
to deubiquitination
DUBs are an important component of the ubiquitin-protea-
some system. They are proteases and can therefore be tar-
geted by activity-dependent probes, which form covalent
bonds with their active sites and have been successfully
applied to other classes of proteases [55,56]. An elegant
strategy using an activity-based approach to target DUBs
has led to the identification of numerous deubiquitinating
activities in cell lysates and the discovery of the new class of
DUBs that contain an OTU domain (a domain characteristic
of the ovarian tumor superfamily of proteins) [57]. Briefly,
ubiquitin fused to a hemagglutinin (HA) epitope tag at its
amino terminus and to one of various cysteine-reactive
probes (which react with cysteine proteases) at the carboxyl
terminus is incubated with total cell lysates. The active site
of each DUB forms a covalent bond with the cysteine-reac-
tive group on the HA-ubiquitin probe (Figure 3a) and can
therefore be immunopurified using the HA tag and subse-
quently identified by mass spectrometry (Figure 3b) [58].
Activity-based ubiquitin probes have also been used to gen-
erate profiles of DUB activity in different cell lines and
tissues and to identify proteins that interact with DUBs
(Figure 3b) [58,59].
The problem of identifying DUBs that react with a specific
ubiquitinated protein has been elegantly addressed using a
collection of RNA-interference (RNAi) vectors that knock
down the expression of more than 50 DUBs in mammalian
cells [60]. Because the steady-state level of ubiquitin conju-
gates reflects the balance between ubiquitination and
deubiquitination, knockdown of the activity of a specific
DUB increases the fraction of the ubiquitinated form of its
substrates. This strategy helped to identify the DUB USP1 as
the deubiquitinating activity that acts on the mono-ubiquiti-
nated version of FANCD2 (a protein defective in the Fanconi
anemia complementation group D2) [60]. A similar collec-
tion of small interfering RNAs (siRNAs) has enabled the
identification of the familial cylindromatosis tumor suppres-
sor gene (CYLD) as a DUB involved in regulation of the
NFB transcriptional control pathway [61]. 
More than 25 years have passed since the initial discovery of
the ubiquitin system. Ubiquitin has since extended its role
from a protein-degradation signal to a regulatory protein
modification that affects all areas of biology. The importance
of the ubiquitin-proteasome system in biology was acknowl-
edged with the 2004 Chemistry Nobel Prize to Aaron
Ciechanover, Avram Hershko, and Irwin Rose, who first estab-
lished its main features. The complexity and significance of
the ubiquitin-proteasome system has started to attract global
approaches that are beginning to make important contribu-
tions to our understanding of the system. Chemistry-based
approaches to deubiquitination have demonstrated the effec-
tiveness of these strategies, and analogous activity-based
probes for studying the ubiquitin transfer will be of similar
importance. Proteomics using mass spectrometry has had a
tremendous impact on the field, as it has helped to describe
the nature and regulation of multi-protein complexes that
themselves regulate the ubiquitin-proteasome system. Large-
scale ubiquitin-profiling experiments have highlighted the
involvement of the system in a wide range of processes and
demonstrated the complexity of ubiquitin-chain topology.
Mass-spectrometric approaches promise to be particularly
powerful in the future because one of the previous limitations -
the inherent non-quantitative nature of these experiments -
has been overcome by stable-isotope-based quantification
strategies [48-50].
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Figure 3
Activity-based profiling of deubiquitinating enzymes and interacting
proteins. (a) Ubiquitin fused to an amino-terminal epitope tag (for
example hemagglutinin, HA) and a carboxy-terminal reactive group forms
a covalent conjugate with deubiquitinating enzymes (DUBs; for details of
the generation of these ubiquitin probes, see [57]). (b) The DUB-
ubiquitin conjugates can be immunopurified using the HA epitope.
Immunopurification under native conditions allows identification of DUBs
and their interacting proteins by mass spectrometry (MS). The
immunopurified fractions can be further separated by gel electrophoresis,
and DUB-ubiquitin conjugates can be detected by anti-HA
immunoblotting. Proteins corresponding to HA-reactive bands can be
eluted from silver-stained gels (not shown) and the DUBs can be
identified by mass spectrometry.
Reactive
group
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HA
HA
Ubiquitin
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DUB           DUB          
Native
purification
Denaturing
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(a)
(b)Some of the global approaches described here for the study
of the ubiquitin system have also been applied to the study of
other ubiquitin-like proteins, such as SUMO, ISG15, and
Nedd8 [62,63]. The strategies that have been proven to be
effective for studying ubiquitin biology will be just as impor-
tant for rapidly advancing our understanding of the role of
the growing family of ubiquitin-like modifiers. 
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